Daniel Holst, MD
Urology · Billings, MTNPI 1174974828
Payments from drug & device makers
What this record shows
This record is dominated by grants: $837 of the $1,359 with a category attached, or 61.6%. Boston Scientific accounts for 85.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $837 and has fallen 95.3% since, to $40 in 2024. That places this record below the midpoint for urology clinicians in MT, where the typical reported total is $1,996.
Across 13 payments — averaging $104.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Medtronic$130
- Hologic Sales And Service, LLC$23
- Teleflex LLC$23
- Laborie Medical Technologies Corp.$17
What the payments were for
- Grants$83762%
- Food & beverage$52238%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $1,167 |
| Medtronic(2 entities) | 2 | $130 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Teleflex LLC | 1 | $23 |
| Laborie Medical Technologies Corp. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,359 in reported general payments places this provider in the 30th percentile of 45 urology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 30 | $21,490 |
| Tamsulosin Hcl | 240 | $3,513 |
| Finasteride | 154 | $1,494 |
| Potassium Citrate ErPotassium Citrate | 18 | $1,468 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $781 |
| Oxybutynin Chloride | 35 | $583 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 18 | $219 |
| Doxazosin Mesylate | 22 | $175 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $98 |
| Oxycodone Hcl | 53 | $84 |
| Ondansetron OdtOndansetron | 29 | $76 |
Paid to pharmacies, not to this prescriber.
Other urology in Billings
- Lisa BlandBillings$4K
- Adam DowellBillings$4K
- Daniel FaaborgBillings$3K
- Daniel SwansonBillings$2K
- Michael HickmanBillings$1K
- Christopher SchreiberBillings$1K
- Karin BrownBillings$997
- Ruth BlumBillings$720
- Robert StockdaleBillings$143
- Lawrence KleeBillings$20
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.